- 03.12.2025 - 08:56
Background: Chronic diseases currently impose a substantial health and financial burden on the Swiss health system. With an ageing population affecting both the demand (patients) and supply (primary care physicians) of healthcare services, this burden is bound to increase. Identifying the magnitude of this burden and factors that can prevent the continuous growth of potentially avoidable hospitalisations is essential.
Methods: We identified PAHs in retrospective routine hospital data and derived numbers of occupied hospital beds, based on cases’ length of stay, and inpatient healthcare expenditures, based on diagnosis-related group payments. We also utilized population forecasts for Switzerland to extrapolate PAH-volume in the base scenario. Additionally, we predicted via linear regression how reduced ageing-induced PCP-availability might affect PAHs. Finally, we explored the potential impact of countermeasures, optimal Guideline-Directed Medical Therapy (GDMT)-implementation, for CHF and COPD.
Key results:
1. CHF-related PAHs: −31% (95% CI: 22.2–37.6%),
1. COPD-related PAHs: −14% (95% CI: 2.2–26.0%) by 2032.
Conclusions: Our study assesses cumulative PAH-trends and is the first to forecast future burden in Switzerland. A strong rise in PAHs and associated inpatient resources was observed for the last decade, with accelerating growth expected throughout the next. A depleting healthcare workforce may exacerbate burden. Optimal GDMT-implementation could potentially curb increases in PAHs. However, methods to reach optimal implementation require further research and policy efforts.
